|
|
||||||||


* Cooperative Research Center for Vaccine Technology, Queensland Institute of Medical Research, Royal Brisbane Hospital, Queensland, Australia; and
Department of Microbiology, Faculty of Public Health, and
Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Merozoite surface protein 1 (MSP1) of malaria parasites undergoes proteolytic processing at least twice before invasion into a new RBC. The 42-kDa fragment, a product of primary processing, is cleaved by proteolytic enzymes giving rise to MSP133, which is shed from the merozoite surface, and MSP119, which is the only fragment carried into a new RBC. In this study, we have identified T cell epitopes on MSP133 of Plasmodium yoelii and have examined their function in immunity to blood stage malaria. Peptides 20 aa in length, spanning the length of MSP133 and overlapping each other by 10 aa, were analyzed for their ability to induce T cell proliferation in immunized BALB/c and C57BL/6 mice. Multiple epitopes were recognized by these two strains of mice. Effector functions of the dominant epitopes were then investigated. Peptides Cm15 and Cm21 were of particular interest as they were able to induce effector T cells capable of delaying growth of lethal P. yoelii YM following adoptive transfer into immunodeficient mice without inducing detectable Ab responses. Homologs of these epitopes could be candidates for inclusion in a subunit vaccine.
This article has been cited by other articles:
![]() |
S. Sridhar, A. Reyes-Sandoval, S. J. Draper, A. C. Moore, S. C. Gilbert, G. P. Gao, J. M. Wilson, and A. V. S. Hill Single-Dose Protection against Plasmodium berghei by a Simian Adenovirus Vector Using a Human Cytomegalovirus Promoter Containing Intron A J. Virol., April 15, 2008; 82(8): 3822 - 3833. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Malhotra, A. N. Wamachi, P. L. Mungai, E. Mzungu, D. Koech, E. Muchiri, A. M. Moormann, and C. L. King Fine Specificity of Neonatal Lymphocytes to an Abundant Malaria Blood-Stage Antigen: Epitope Mapping of Plasmodium falciparum MSP133 J. Immunol., March 1, 2008; 180(5): 3383 - 3390. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Huaman, L. B. Martin, E. Malkin, D. L. Narum, L. H. Miller, S. Mahanty, and C. A. Long Ex Vivo Cytokine and Memory T Cell Responses to the 42-kDa Fragment of Plasmodium falciparum Merozoite Surface Protein-1 in Vaccinated Volunteers J. Immunol., February 1, 2008; 180(3): 1451 - 1461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Burns Jr., P. R. Flaherty, P. Nanavati, and W. P. Weidanz Protection against Plasmodium chabaudi Malaria Induced by Immunization with Apical Membrane Antigen 1 and Merozoite Surface Protein 1 in the Absence of Gamma Interferon or Interleukin-4 Infect. Immun., October 1, 2004; 72(10): 5605 - 5612. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Belnoue, F. T. M. Costa, T. Frankenberg, A. M. Vigario, T. Voza, N. Leroy, M. M. Rodrigues, I. Landau, G. Snounou, and L. Renia Protective T Cell Immunity against Malaria Liver Stage after Vaccination with Live Sporozoites under Chloroquine Treatment J. Immunol., February 15, 2004; 172(4): 2487 - 2495. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rainczuk, T. Scorza, P. M. Smooker, and T. W. Spithill Induction of Specific T-Cell Responses, Opsonizing Antibodies, and Protection against Plasmodium chabaudi adami Infection in Mice Vaccinated with Genomic Expression Libraries Expressed in Targeted and Secretory DNA Vectors Infect. Immun., August 1, 2003; 71(8): 4506 - 4515. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Makobongo, G. Riding, H. Xu, C. Hirunpetcharat, D. Keough, J. de Jersey, P. Willadsen, and M. F. Good The purine salvage enzyme hypoxanthine guanine xanthine phosphoribosyl transferase is a major target antigen for cell-mediated immunity to malaria PNAS, March 4, 2003; 100(5): 2628 - 2633. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |